Murray Brunt, A., Haviland, J. S., Wheatley, D. A., Sydenham, M. A., Alhasso, A., Bloomfield, D. J., Chan, C., Churn, M., Cleator, S., Coles, C. E., Goodman, A., Harnett, A., Hopwood, P., Kirby, A. M., Kirwan, C. C., Morris, C., Nabi, Z., Sawyer, E., Somaiah, N., Stones, L., Syndikus, I., Bliss, J. M., Yarnold, J. R., & , (2020). hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet, 395(10237), 1613–1626. http://access.bl.uk/ark:/81055/vdc_100103818758.0x000049